Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.

Maron BJ, Estes NA 3rd, Maron MS, Almquist AK, Link MS, Udelson JE.

Circulation. 2003 Jun 17;107(23):2872-5. Review. No abstract available.

2.

Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.

Adabag AS, Maron BJ.

Ann Noninvasive Electrocardiol. 2007 Apr;12(2):171-80. Review. No abstract available.

PMID:
17593187
4.

Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Begley DA, Mohiddin SA, Tripodi D, Winkler JB, Fananapazir L.

Pacing Clin Electrophysiol. 2003 Sep;26(9):1887-96.

PMID:
12930505
5.

Aborted sudden cardiac death in hypertrophic cardiomyopathy.

Maron BJ, Casey SA, Almquist AK.

J Cardiovasc Electrophysiol. 1999 Feb;10(2):263. No abstract available.

PMID:
10090231
6.

Risk stratification in hypertrophic cardiomyopathy: fact or fiction?

Hess OM.

J Am Coll Cardiol. 2003 Sep 3;42(5):880-1. No abstract available.

7.

Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.

Maron BJ.

Cardiol Rev. 2002 May-Jun;10(3):173-81. Review.

PMID:
12047795
8.

Triple type of obstruction in hypertrophic cardiomyopathy.

Efthimiadis GK, Parcharidou DG, Vassilikos V, Giannakoulas G, Pliakos C, Parcharidis GE.

J Cardiovasc Med (Hagerstown). 2008 Nov;9(11):1156-8. doi: 10.2459/JCM.0b013e3283108803. No abstract available.

PMID:
18852593
9.

Sudden death and hypertrophic cardiomyopathy: a review.

Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.

Can J Cardiol. 2005 Apr;21(5):441-8. Review.

PMID:
15861263
10.

Sudden death as a presenting symptom of hypertrophic cardiomyopathy: treatment with an implantable cardioverter defibrillator.

Talard P, Lévy S, Bonal J, Paganelli F, Bouchiat C, Cellarier G, Dussarat GV.

Pacing Clin Electrophysiol. 1996 Aug;19(8):1264-7.

PMID:
8865227
11.

Extreme hypertrophic cardiomyopathy.

Maron BJ, Casey SA, Almquist AK.

Heart. 2004 Jan;90(1):24. No abstract available.

12.

[Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].

Maron BJ.

Rev Esp Cardiol. 2006 Jun;59(6):527-30. Spanish. No abstract available.

13.

[Sudden death and ventricular fibrillation of possible ischemic origin in a boy with hypertrophic myocardiopathy].

Gutiérrez Díez A, Tamariz-Martel Moreno A, Baño Rodrigo A, Serrano González A.

Rev Esp Cardiol. 2000 Feb;53(2):290-3. Review. Spanish.

14.

Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.

Cuoco FA, Spencer WH 3rd, Fernandes VL, Nielsen CD, Nagueh S, Sturdivant JL, Leman RB, Wharton JM, Gold MR.

J Am Coll Cardiol. 2008 Nov 18;52(21):1718-23. doi: 10.1016/j.jacc.2008.07.061.

15.
17.

[Hypertrophic cardiomyopathy and sudden cardiac death--ICD indications in the margin of uncertainty].

Fauchère I, Duru F.

Praxis (Bern 1994). 2009 Aug 26;98(17):941-52. doi: 10.1024/1661-8157.98.17.941. Review. German.

PMID:
19711287
18.

Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Slade AK, Camm AJ.

Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:37-49. Review.

PMID:
8734163
19.

[Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].

Hentati M, Ben Ameur I, Kechida Z, Charfeddine H, Hached L, Grati Z, Kammoun S.

Tunis Med. 2003;81 Suppl 8:675-9. French.

PMID:
14608758
20.

Can sudden cardiac death be prevented?

Maron BJ.

Cardiovasc Pathol. 2010 Nov-Dec;19(6):329-35. doi: 10.1016/j.carpath.2010.03.002. Epub 2010 Apr 8.

PMID:
20378375
Items per page

Supplemental Content

Write to the Help Desk